Monthly Archives: June, 2019
U.S. FDA Approves IB-Stim, First Medical Device for Irritable Bowel Syndrome (IBS) Pain in Adolescents, June 2019
About two weeks ago, the U.S Food and Drug Administration (FDA) approved marketing of the IB-Stim device, for use in adolescents, ages 11-18, with functional gastrointestinal pain related to irritable bowel syndrome (IBS). IB-Stim, developed by Innovative Health Solutions in Indiana, is a small nerve stimulator device powered by a battery and intended to be …
Online Research Survey on Chronic Abdominal Pain, Stanford University and IFFGD, June 2019
The following anonymous and confidential research survey is open to adults 18 years old or older from any country who have had a chronic abdominal pain condition (IBS and/or many others) for at least 6 months. The survey will ask demographic information, symptom information, and treatment information for current or past interventions and their level …
IBS IMPACT 